← Back to Search

Sildenafil 25mg Oral Tablet for Prostate Cancer

Phase 3
Waitlist Available
Led By Kuwong B Mwamukonda, MD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post surgery
Awards & highlights

Study Summary

This trial will compare the effectiveness of two drugs in helping men regain erectile function after surgery for prostate cancer.

Eligible Conditions
  • Prostate Cancer
  • Erectile Dysfunction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Erectile function
Secondary outcome measures
Penile length

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Sildenafil 25mg Oral TabletActive Control1 Intervention
25mg sildenafil citrate twice daily
Group II: PentoxifyllineActive Control1 Intervention
400mg pentoxifylline twice daily
Group III: PlaceboPlacebo Group1 Intervention
placebo twice daily

Find a Location

Who is running the clinical trial?

Walter Reed National Military Medical CenterFED
138 Previous Clinical Trials
33,834 Total Patients Enrolled
1 Trials studying Prostate Cancer
8 Patients Enrolled for Prostate Cancer
Brooke Army Medical CenterLead Sponsor
119 Previous Clinical Trials
26,379 Total Patients Enrolled
Kuwong B Mwamukonda, MDPrincipal Investigator - Brooke Army Medical Center
Brooke Army Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~22 spots leftby May 2025